Skip to main content
. 2020 Dec 1;202(11):1520–1530. doi: 10.1164/rccm.201910-2021OC

Table 3.

Outcomes among the Total Population and Stratified by Primary Diagnosis

  Entire Cohort [n (%)]
Primary Diagnosis Respiratory Failure [n (%)]
Primary Diagnosis Asthma Exacerbation [n (%)]
  Total (N = 53,654) Noninvasive Ventilation (n = 13,540) No Noninvasive Ventilation (n = 40,114) Total (n = 17,387) Noninvasive Ventilation (n = 6,457) No Noninvasive Ventilation (n = 10,930) Total (n = 37,361) Noninvasive Ventilation (n = 7,510) No Noninvasive Ventilation (n = 29,851)
Invasive mechanical ventilation 14,498 (27.0) 3,013 (22.3) 11,485 (28.6) 8,829 (50.8) 1,942 (30.1) 6,887 (63.0) 6,156 (16.6) 1,175 (15.6) 4,981 (16.7)
In-hospital mortality 1,291 (2.4) 223 (1.7) 1,068 (2.7) 860 (5.0) 151 (2.3) 709 (6.5) 443 (1.2) 75 (1.0) 368 (1.2)
Propensity-matched cohort n = 25,450 n = 12,725 n = 12,725 n = 11,350 n = 5,675 n = 5,675 n = 14,846 n = 7,423 n = 7,423
 Invasive mechanical ventilation 8,197 (31.7) 2,897 (22.4) 5,300 (40.1) 5,095 (44.9) 1,808 (35.5) 3,287 (64.5) 3,111 (21.0) 1,161 (15.6) 1,950 (26.8)
 In-hospital mortality 605 (2.3) 216 (1.7) 389 (3.0) 390 (3.4) 137 (2.4) 253 (4.5) 197 (1.3) 74 (1.0) 123 (1.7)